Nanotechnology Now

Our NanoNews Digest Sponsors







Heifer International

Wikipedia Affiliate Button


Home > Press > A New Therapy Without Side Effects Could Improve Dramatically Chemotherapy

Abstract:
This significant progress -based on nanotechnology- has been achieved by researchers of the universities of Granada, Edimbourgh and Kebangsaan (Malaisie). This therapy is based on the encapsulation of a catalyst (palladium) into microspheres, to synthesize artificial materials or activate drugs into human cells, thus avoiding any toxicity.

A New Therapy Without Side Effects Could Improve Dramatically Chemotherapy

Spain | Posted on July 19th, 2011

Researchers of the University of Granada and Edimbourgh have developed a new therapy for cancer based on nanotechnology that might improve significantly chemotherapy, as it has not cause side effects.

This therapy is based on the encapsulation of a catalyst (palladium) into microspheres, to synthesize artificial materials or activate drugs within human cells, thus avoiding any toxicity. This system captures palladium within its microstructure. Palladium is a metal not found naturally in human cells that allows to catalyze chemical reactions within cells without altering its basic functions such as protein synthesis and metabolism. This technique allows to "create" anti-cancer drugs within cells, which could be used for the specific treatment of tumors and would improve dramatically current chemotherapy treatments.

The results of this research -conducted in collaboration with the University of Kebangsaan (Malasia)- were recently published in the prestigious journal Nature Chemistry.

Participation Of The University of Granada

Rosario María Sánchez Martín -the researcher that has developed this technology at the School of Chemistry of the University of Edimbourgh- has recently joined the Department of Pharmaceutical and Organic Chemistry of the University of Granada.

Another of the scientists that forms this research group, Asier Unciti Broceta, did his undergraduate studies and doctorate at the Department of Pharmaceutical and Organic Chemistry at the University of Granada, and he currently continues his successful career in Edinburgh, where he was recently named Fellow of the Edinburgh Cancer Research UK Centre, and received the award of Young Life Scientist of the Year 2010 in Scotland. Additionally, he has founded a new company, Deliverics Ltd, based on one of his patents.

Researchers pointed that, given the wide range of therapeutic applications of nanotechnology, this research will be further developed by University of Granada professor Dr Sanchez Martin, who will continue her collaboration with the research group conducted by professor Mark Bradley of the University of Edimbourgh.

####

For more information, please click here

Contacts:
Rosario María Sánchez Martín
Department of Pharmaceutical and Organic Chemistry
University of Granada
Phone:+0034 958 246 678

Copyright © Universidad de Granada

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beneq’s comprehensive industrial Thin Film Coating Services shorten time to market June 18th, 2013

Research and industry frontrunners gather in Dublin at the EuroNanoForum, Europe’s largest nanotechnology conference June 18th, 2013

Imec presents 4K2K CMOS image sensor together with Panasonic: The co-developed imager sensor chip targets high speed, high resolution imaging applications such as next generation HDTV June 18th, 2013

Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013

Nanomedicine

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013

European Technology Platform for Nanomedicine and Nanomed2020 European Consortium Launch the Nanomedicine Award June 17th, 2013

Discoveries

Imec presents 4K2K CMOS image sensor together with Panasonic: The co-developed imager sensor chip targets high speed, high resolution imaging applications such as next generation HDTV June 18th, 2013

Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013

Announcements

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013

Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013

Research partnerships

Imec presents 4K2K CMOS image sensor together with Panasonic: The co-developed imager sensor chip targets high speed, high resolution imaging applications such as next generation HDTV June 18th, 2013

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Nano-thermometer enables first atomic-scale heat transfer measurements June 13th, 2013

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project








abbigliamento uomo
Computer Accessories
© Copyright 1999-2013 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE